JP2024541975A5 - - Google Patents
Info
- Publication number
- JP2024541975A5 JP2024541975A5 JP2024525308A JP2024525308A JP2024541975A5 JP 2024541975 A5 JP2024541975 A5 JP 2024541975A5 JP 2024525308 A JP2024525308 A JP 2024525308A JP 2024525308 A JP2024525308 A JP 2024525308A JP 2024541975 A5 JP2024541975 A5 JP 2024541975A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- disease
- independently
- halogen
- structural part
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163276073P | 2021-11-05 | 2021-11-05 | |
| US63/276,073 | 2021-11-05 | ||
| PCT/US2022/079290 WO2023081812A2 (en) | 2021-11-05 | 2022-11-04 | Akt3 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541975A JP2024541975A (ja) | 2024-11-13 |
| JP2024541975A5 true JP2024541975A5 (cg-RX-API-DMAC10.html) | 2025-11-12 |
Family
ID=86242221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525308A Pending JP2024541975A (ja) | 2021-11-05 | 2022-11-04 | Akt3モジュレーター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250074905A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4426706A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024541975A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240116621A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118488956A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022381198A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3236906A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL312439A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024005207A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023081812A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021212111A1 (en) * | 2020-04-17 | 2021-10-21 | Augusta University Research Institute, Inc. | Compositions and methods for treating leukemia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3854480A (en) | 1969-04-01 | 1974-12-17 | Alza Corp | Drug-delivery system |
| US4675189A (en) | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
| US4452775A (en) | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5407686A (en) | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5736152A (en) | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US7534423B2 (en) | 2003-03-28 | 2009-05-19 | Faron Pharmaceuticals Oy | Method for inducing an elevated level of adenosine in an individual |
| WO2006135627A2 (en) * | 2005-06-10 | 2006-12-21 | Merck & Co., Inc. | Inhibitors of akt activity |
| CA2678180A1 (en) | 2007-02-13 | 2008-12-04 | Northeastern University | Methods and compositions for improving immune responses |
| US11291719B2 (en) * | 2016-01-15 | 2022-04-05 | Augusta University Research Institute, Inc. | Methods and compositions for modulating Akt3 |
| US20230295114A1 (en) * | 2020-05-08 | 2023-09-21 | Georgiamune Llc | Akt3 modulators |
-
2022
- 2022-11-04 IL IL312439A patent/IL312439A/en unknown
- 2022-11-04 KR KR1020247018640A patent/KR20240116621A/ko active Pending
- 2022-11-04 JP JP2024525308A patent/JP2024541975A/ja active Pending
- 2022-11-04 AU AU2022381198A patent/AU2022381198A1/en active Pending
- 2022-11-04 CA CA3236906A patent/CA3236906A1/en active Pending
- 2022-11-04 US US18/707,078 patent/US20250074905A1/en active Pending
- 2022-11-04 WO PCT/US2022/079290 patent/WO2023081812A2/en not_active Ceased
- 2022-11-04 EP EP22891084.0A patent/EP4426706A4/en active Pending
- 2022-11-04 MX MX2024005207A patent/MX2024005207A/es unknown
- 2022-11-04 CN CN202280087271.8A patent/CN118488956A/zh active Pending